Parkmead Group (The)

Issue of Equity & TVR

RNS Number : 6184A
Parkmead Group (The) PLC
02 June 2021

2 June 2021


The Parkmead Group plc

("Parkmead", "the Company" or "the Group")


Issue of Equity and Total Voting Rights

The Parkmead Group announces that it has issued 85,134 ordinary shares of 1.5 pence each in the Company (the "Ordinary Shares") in order to satisfy a contractual commitment under the Company's Deferred Share Payment Plan (DSP).  

Accordingly, an application has been made for the 85,134 Ordinary Shares to be admitted to trading on AIM, which is expected to be on or around 3 June 2021. Post admission of the Ordinary Shares, the Company's issued share capital will consist of 109,266,931 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury. Therefore, the total number of voting rights in the Company will be 109,266,931.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.



The Parkmead Group plc

+44 (0) 1224 622200

Tom Cross (Executive Chairman) 

Ryan Stroulger (Chief Financial Officer) 

finnCap Ltd (NOMAD and Broker to


Marc Milmo / Emily Watts - Corporate Finance

  +44 (0) 20 7220 0500


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.